Summary
It is well known that the un-competitive N-methyl-D-aspartate (NMDA) receptor antagonist phencyclidine can induce a syndrome in humans that mimics both positive and negative symptoms of schizophrenia. In the light of this observation, it has been hypothesised that schizophrenia might be due to a hypofunction of central glutamate systems. A glycine agonist, by strengthening glutamatergic transmission, has been suggested to be useful as treatment. A crucial issue is the uncertainty regarding the degree of saturation of the glycine site associated with the NMDA receptor. The purpose of this study was to investigate if it is possible to strengthen NMDA receptor-mediated neurotransmission by modulating the associated glycine site. The effects of systemic and intraventricular administration of glycine, D-serine and L-serine on the hyperactivity induced in mice by the uncompetitive NMDA receptor antagonist MK-801 were tested. Systemically administered glycine and D-serine were found to decrease MK-801-induced hyperactivity. Intraventricularly administered D-serine in doses of 50 or 100μg/side was found to decrease MK-801-induced hyperactivity during the second half hour of registration; L-serine given in the same doses did not affect the MK-801-induced hyperactivity during this period. These data may suggest that the NMDA receptor-associated glycine site is not saturated in vivo.
Similar content being viewed by others
References
Bristow DR, Bowery NG, Woodruff GN (1986) Light microscopic autoradiographic localisation of [3H]glycine and [3H]strychnine binding sites in rat brain. Eur J Pharmacol 126: 303–307
Carlsson A (1988) The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1: 179–186
Carlsson A (1992) Neurotransmitter dysfunction in schizophrenia. Proceedings, 7th International Symposium of the Tokyo Institute of Psychiatry, October 19–20 Tokyo, Japan, pp 167–183
Carlsson M, Carlsson A (1990) Interactions between glutamatergic and monoaminergic systems within the basal ganglia — implications for schizophrenia and Parkinson's disease. TINS 13: 272–276
Chouinard ML, Gaitan D, Wood PL (1993) Presence of the N-methyl-d-aspartate-associated glycine receptor agonist, d-serine, in human temporal cortex: comparison of normal, Parkinson, and Alzheimer tissues. J Neurochem 61: 1561–1564
Contreras PC (1990) D-serine antagonized phencyclidine- and MK-801-induced stereotyped behaviour and ataxia. Neuropharmacology 29: 291–293
Cuzick J (1985) A Wilcoxon-type test for trend. Stat Med 4: 87–90
Garland Bunney B, Bunney WE Jr, Carlsson A (1995) Psychopharmacology: the fourth generation of progress. Raven Press, New York, pp 1205–1214
Hashimoto A, Oka T, Nishikawa T (1995) Extracellular concentration of endogenous free d-serine in the rat brain as revealed by in vivo microdialysis. Neurosci 66: 635–643
Javitt DC (1987) Negative schizophrenic symptomatology and PCP (phencyclidine) model of schizophrenia. Hillside J Clin Psych 9: 12–33
Kim JS, Kornhuber HH, Schmid-Burgk W, Holzmuller B (1980) Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci Lett 20: 379–382
Lahti AC, Koffel B, LaPorte D, Tamminga CA (1995) Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 13: 9–19
Lehmann J, Colpaert F, Canton H (1991) Clutamate and glycine co-activate while polyamines merely modulate the NMDA receptor complex. Prog Neuropsychopharmacol Biol Psychiatry 15: 183–190
Lodge D, Johnson KM (1990) Noncompetitive excitatory amino acid receptor antagonists. TIPS 11: 81–86
MacDonald JF, Nowak LM (1990) Mechanisms of blockade of excitatory amino acid receptor channels. TIPS 11: 167–172
McBain CJ, Kleckner NW, Wyrick S, Dingledine R (1989) Structural requirements for activation of the glycine coagonist site of N-methyl-D-aspartate receptors expressed in xenopus oocytes. Mol Pharmacol 36: 556–565
McDonald JW, Penney JB, Johnston MV, Young AB (1990) Characterization and regional distribution of strychnine-insensitive [3H]glycine binding sites in rat brain by quantitative receptor autoradiography. Neurosci 35: 653–668
Nilsson M, Carlsson ML (1997) The glycine antagonist (+)-HA-966 injected into the nucleus accumbens stimulates locomotion in mice. J Neural Transm 104: 419–425
Patel J, Zinkand WC, Thompson C, Keith R, Salama A (1990) Role of glycine in the N-methyl-D-aspartate-mediated neuronal cytotoxicity. J Neurochem 54: 849–854
Pullan LM, Powel RJ (1992) Comparison of binding at strychnine-sensitive (inhibitory glycine receptor) and strychnine-insensitive (N-methyl-D-aspartate receptor) glycine binding sites. Neurosci Lett 148: 199–201
Rao TS, Cler JA, Emmett MR, Mick SJ (1990) Glycine, glycinamide and D-serine act as positive modulators of signal transduction at the N-methyl-D-aspartate (NMDA) receptor in vivo: differential effects on mouse cerebellar cyclic guanosine monophosphate levels. Neuropharmacology 29: 1075–1080
Reynolds IJ, Miller RJ (1988) Multiple sites for the regulation of the N-methyl-D-aspartate receptor. Mol Pharmacol 33: 581–584
Salt TE (1989) Modulation of NMDA receptor-mediated responses by glycine and dserine in the rat thalamus in vivo. Brain Res 481: 403–406
Schell MJ, Molliver ME, Snyder SH (1995) D-serine, an endogenous synaptic modulator: localization to astrocytes and glutamate-stimulated release. Proc Natl Acad Sci USA 92: 3948–3952
Singh L, Oles RJ, Tricklebank MD (1990) Modulation of seizure susceptibility in the mouse by the strychnine-insensitive glycine recognition site of the NMDA receptor/ion channel complex. Br J Pharmacol 99: 285–288
Tanii Y, Nishikawa T, Hashimoto A, Takahashi K (1994) Stereoselective antagonism by enantiomers of alanine and serine of phencyclidine-induced hyperactivity, stereotypy and ataxia in the rat. J Pharmacol Exp Ther 269: 1040–1048
Thomson AM (1990) Glycine is a coagonist at the NMDA receptor/channel complex. Prog Neurobiol 35: 53–74
Toth E, Lajtha A (1986) Antagonism of phencyclidine-induced hyperactivity by glycine in mice. Neurochem Res 11: 393–400
White WF, Brown KL, Frank DM (1989) Glycine binding to rat cortex and spinal cord: binding characteristics and pharmacology reveal distinct populations of sites. J Neurochem 53: 503–512
Wong EHF, Kemp JA (1991) Sites for antagonism on the N-methyl-D-aspartate receptor channel complex. Ann Rev Pharmacol Toxicol 31: 401–425
Wong EHF, Kemp JA, Priestley T, Knight AR, Woodruff GN, Iversen LL (1986) The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc Natl Acad Sci USA 83: 7104–7108
Wood PL (1995) The co-agonist concept: is the NMDA-associated glycine receptor saturated in vivo? Life Sci 57: 301–310
Wood PL, Emmett MR, Rao TS, Micks S, Cler J, Lyengar S (1989) In vivo modulation of the NMDA receptor complex by d-serine. Potentiation of on-going neuronal activity as evidenced by increased cerebellar cGMP. J Neurochem 53: 979–981
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nilsson, M., Carlsson, A. & Carlsson, M.L. Glycine and D-serine decrease MK-801-induced hyperactivity in mice. J. Neural Transmission 104, 1195–1205 (1997). https://doi.org/10.1007/BF01294720
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01294720